Low aBMD is prevalent in FRDA, but few of even the highest risk individuals are undergoing screening. Our findings highlight potential missed opportunities for the screening and treatment of low aBMD in FRDA.
Tuesday, March 15, 2022
Bone Mineral Density and Current Bone Health Screening Practices in Friedreich’s Ataxia
Dunn J, Tamaroff J, DeDio A, Nguyen S, Wade K, Cilenti N, Weber DR, Lynch DR and McCormack SE (2022) Bone Mineral Density and Current Bone Health Screening Practices in Friedreich’s Ataxia. Front. Neurosci. 16:818750. doi: 10.3389/fnins.2022.818750
